未变异的RRAS2成为产后与产后相关的三阴性乳腺癌中的关键瘤基因
Claudia Cifuentes1, Clara L Oeste1,2, Isabel Fernández-Pisonero3
1Immune System Development and Function Program, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Nicolás Cabrera 1, Madrid, 28049, Spain.
Molecular cancer
|July 10, 2024
概括
过度表达RRAS2基因驱动三阴性乳腺癌 (TNBC) 的发展,特别是在孕妇中. 这一发现为乳腺癌 (BC) 病原和潜在的治疗点提供了新的见解.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种对当前疗法有抗性的侵袭性亚型.
- 虽然平价降低了整体乳腺癌 (BC) 风险,但怀孕与产后TNBC风险增加有关.
- 没有任何单一的基因变异被确定为BC的普遍驱动因素.
研究的目的:
- 调查RRAS2的作用,一个罕见突变的RAS相关的GTPase,在乳腺癌的发展.
- 确定RRAS2过度表达是否是TNBC的驱动因素,特别是在怀孕的背景下.
主要方法:
- 在乳腺上皮细胞中产生过度表达野生类型人类RRAS2的条件敲入小鼠.
- 使用RT-qPCR对RRAS2表达,SNP rs8570频率和瘤和非瘤样本中的基因组DNA放大进行了分析.
主要成果:
- 在小鼠中RRAS2过度表达诱导了100%的雌性TNBC,以怀孕依赖的方式.
- 野生型RRAS2在68%的人类BC瘤中过度表达,在TNBC和年轻的患者中患病率更高.
- 增加RRAS2替代代基因 (SNP rs8570) 的流行率和基因放大表明与BC.的因果关系.
结论:
- 非突变的RRAS2过度表达是大多数乳腺癌的关键驱动因素,特别是TNBC.
- 与怀孕相关的乳腺癌风险可能与RRAS2活性有关.
- 对于特定的乳腺癌亚型来说,RRAS2是潜在的治疗标.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


